Recruiting

Power Doppler Ultrasound

Sponsor:

Western University, Canada

Code:

NCT03861507

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prostate Brachytherapy

Study Details

Brief summary:

This study involves patients who are scheduled for standard care brachytherapy of focal tumours within the prostate, which is normally performed under standard 2-dimensional (2D) ultrasound guidance. The purpose of this study is the acquire power Doppler ultrasound while using a simple oscillator in physical contact with the end of a brachytherapy needle. The vibrations along the needle should be visible in the power Doppler ultrasound, helping to visualize the needle position within the anatomy.

Conditions

Prostate Cancer

Study ID

NCT03861507

Start date

Mar 4, 2020

Status verified date

Mar, 2025

Completion date

Dec, 2025

Anticipated

Primary completion date

Aug, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Male, aged 18 years or older
  • Willing to provide written consent
  • Pathologically confirmed prostate cancer on previous biopsy
  • Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care.

Exclusion Criteria:

  • • Previous radiotherapy to the prostate

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

other: Patient

Patient undergoing standard care prostate high dose rate brachytherapy.

Interventions

Prostate Brachytherapy

High dose - rate (HDR) brachytherapy

Primary outcome measure

  • Needle Trajectory [ Time Frame: 1 month following data collection ]

Central Contacts and Locations

Central contacts

Aaron Fenster

5199315777afenster@uwo.ca

Locations

Victoria Hospital

Recruiting

London, Ontario, Canada, N6A 5W9

Contacts

Douglas Hoover, PhD

Douglas.Hoover@lhsc.on.ca

More Information

Sponsor

Western University, Canada

Last update posted

Mar 28, 2025

Last verified

Mar, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Western University, Canada on 2025-03-28.